NanHua Bio-medicine Co (SZSE:000504) ROCE % : -2.22% (As of Mar. 2024)

View and export this data going back to 1992. Start your Free Trial

What is NanHua Bio-medicine Co ROCE %?

ROCE % measures how well a company generates profits from its capital. It is calculated as EBIT divided by Capital Employed, where Capital Employed is calculated as Total Assets minus Total Current Liabilities. NanHua Bio-medicine Co's annualized ROCE % for the quarter that ended in Mar. 2024 was -2.22%.

NanHua Bio-medicine Co ROCE % Historical Data

The historical data trend for NanHua Bio-medicine Co's ROCE % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

NanHua Bio-medicine Co ROCE % Chart

NanHua Bio-medicine Co Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

ROCE %

Get a 7-Day Free Trial

22.40

16.67

-11.22

-8.48

-16.56

NanHua Bio-medicine Co Quarterly Data
	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
ROCE %	Get a 7-Day Free Trial															14.55	-16.08	57.45	-91.39	-2.22

NanHua Bio-medicine Co ROCE % Calculation

NanHua Bio-medicine Co's annualized ROCE % for the fiscal year that ended in Dec. 2023 is calculated as:

ROCE %	=	EBIT	/	( (Capital Employed	+	Capital Employed)	/ count )
		(A: Dec. 2023 )		(A: Dec. 2022 )		(A: Dec. 2023 )
	=	EBIT	/	( ( (Total Assets - Total Current Liabilities)	+	(Total Assets - Total Current Liabilities) )	/ count )
		(A: Dec. 2023 )		(A: Dec. 2022 )		(A: Dec. 2023 )
	=	-34.534	/	( ( (553.366 - 455.152)	+	(771.383 - 452.397) )	/ 2 )
	=	-34.534	/	( (98.214	+	318.986)	/ 2 )
	=	-34.534	/	208.6
	=	-16.56 %

NanHua Bio-medicine Co's ROCE % of for the quarter that ended in Mar. 2024 is calculated as:

ROCE %	=	EBIT ⁽¹⁾	/	( (Capital Employed	+	Capital Employed)	/ count )
		(Q: Mar. 2024 )		(Q: Dec. 2023 )		(Q: Mar. 2024 )
	=	EBIT	/	( ( (Total Assets - Total Current Liabilities)	+	(Total Assets - Total Current Liabilities) )	/ count )
		(Q: Mar. 2024 )		(Q: Dec. 2023 )		(Q: Mar. 2024 )
	=	-7.072	/	( ( (771.383 - 452.397)	+	(611.303 - 294.377) )	/ 2 )
	=	-7.072	/	( ( 318.986	+	316.926 )	/ 2 )
	=	-7.072	/	317.956
	=	-2.22 %

(1) Note: The EBIT data used here is four times the quarterly (Mar. 2024) EBIT data.

NanHua Bio-medicine Co (SZSE:000504) ROCE % Explanation

ROCE % can be especially useful when comparing the performance of capital-intensive companies. Unlike ROE %, which indicates the profitability of Shareholders Equity, ROCE % also considers long-term debt in Capital Employed. This can be helpful when analyzing companies with significant debt, as the result is neutralized by taking debt into consideration.

Generally speaking, a higher ROCE % indicates a stonger profitability for a company. Moreover, it is important to look at the ratio from a long term perspective. Investors tend to favor companies with stable and rising ROCE % trend over those with volatile ones.

NanHua Bio-medicine Co ROCE % Related Terms

Thank you for viewing the detailed overview of NanHua Bio-medicine Co's ROCE % provided by GuruFocus.com. Please click on the following links to see related term pages.

NanHua Bio-medicine Co (SZSE:000504) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » NanHua Bio-medicine Co Ltd (SZSE:000504) » Definitions » ROCE %

Traded in Other Exchanges

N/A

Address

13th Floor, South West, Tianxin 3 Choi Building, Changsha, CHN, 410015

Website

http://www.nhbiogroup.com

NanHua Bio-medicine Co Ltd is engaged in stem cells, immune cells and tissue engineering industry.

NanHua Bio-medicine Co (SZSE:000504) Headlines

No Headlines